Zymergen Inc. (ZY)

Zymergen Inc. (ZY) — VMCI valuation read

Composite valuation read on ZY: VMCI 45/100 against a Basic Materials sector median of 50. The 5-point below-median print is the headline number for Zymergen Inc., and at the mid-cap tier it reflects how the five pillars combine into a single decision-grade score.

Trailing 30-day insider activity for ZY: nothing material on SEC EDGAR. With the Form 4 channel quiet, the price-vs-DCF gap and the trailing margin trend carry more weight in the active read.

**Investor frame.** Value, quality, risk in three lines on ZY: ZY trades at 19.0x earnings, 6% above the Basic Materials median of 18.0x; ROIC of 13.0% sits 3.0pp above the Basic Materials median (10.0%); net debt to EBITDA of -1.2x leaves covenant headroom. EV/EBITDA at 14.0x versus 12.0x for Basic Materials closes the value frame.

ZY fell 2.2% over the trailing 7 days, with a +7.9% read on a 30-day basis.